Arachidonic acid metabolites and their role in inflammatory bowel disease. An update requiring addition of a pathway - PubMed (original) (raw)
Arachidonic acid metabolites and their role in inflammatory bowel disease. An update requiring addition of a pathway
M Donowitz. Gastroenterology. 1985 Feb.
No abstract available
Similar articles
- Modulation of human colonic arachidonic acid metabolism by sulfasalazine.
Hawkey CJ, Boughton-Smith NK, Whittle BJ. Hawkey CJ, et al. Dig Dis Sci. 1985 Dec;30(12):1161-5. doi: 10.1007/BF01314051. Dig Dis Sci. 1985. PMID: 2866075 - [Arachidonic acid metabolism in inflammatory bowel disease--with reference to cyclooxygenase products].
Yamazaki H, Hiwatashi N, Goto Y. Yamazaki H, et al. Nihon Shokakibyo Gakkai Zasshi. 1985 Oct;82(10):2562-8. Nihon Shokakibyo Gakkai Zasshi. 1985. PMID: 3936952 Japanese. No abstract available. - Effects of sulfasalazine and a sulfasalazine analogue on the formation of lipoxygenase and cyclooxygenase products.
Tornhamre S, Edenius C, Smedegård G, Sjöquist B, Lindgren JA. Tornhamre S, et al. Eur J Pharmacol. 1989 Oct 10;169(2-3):225-34. doi: 10.1016/0014-2999(89)90019-8. Eur J Pharmacol. 1989. PMID: 2572437 - Drug treatment and formation of eicosanoids in patients with chronic inflammatory bowel disease.
Lauritsen K. Lauritsen K. Dan Med Bull. 1989 Sep;36(4):378-93. Dan Med Bull. 1989. PMID: 2572403 Review. No abstract available. - Eicosanoids as regulators of pancreatic islet hormone secretion.
Pek SB, Walsh MF. Pek SB, et al. Adv Prostaglandin Thromboxane Leukot Res. 1985;13:221-30. Adv Prostaglandin Thromboxane Leukot Res. 1985. PMID: 2988311 Review. No abstract available.
Cited by
- In vivo effects of orally administered prednisolone on prostaglandin and leucotriene production in ulcerative colitis.
Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J. Lauritsen K, et al. Gut. 1987 Sep;28(9):1095-9. doi: 10.1136/gut.28.9.1095. Gut. 1987. PMID: 2824300 Free PMC article. - Source of endogenous arachidonate and 5-lipoxygenase products in human neutrophils stimulated by bradykinin and A23187.
Nielsen OH, Bukhave K, Ahnfelt-Rønne I, Rask-Madsen J. Nielsen OH, et al. Gut. 1988 Mar;29(3):319-24. doi: 10.1136/gut.29.3.319. Gut. 1988. PMID: 2833432 Free PMC article. - Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease.
Stevens C, Walz G, Singaram C, Lipman ML, Zanker B, Muggia A, Antonioli D, Peppercorn MA, Strom TB. Stevens C, et al. Dig Dis Sci. 1992 Jun;37(6):818-26. doi: 10.1007/BF01300378. Dig Dis Sci. 1992. PMID: 1587185 - Inflammatory bowel disease.
Van Rosendaal GM. Van Rosendaal GM. CMAJ. 1989 Jul 15;141(2):113-23; discussion 123-4. CMAJ. 1989. PMID: 2568163 Free PMC article. Review. - Inflammatory intermediaries in inflammatory bowel disease.
Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J. Lauritsen K, et al. Int J Colorectal Dis. 1989;4(2):75-90. doi: 10.1007/BF01646865. Int J Colorectal Dis. 1989. PMID: 2664059 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources